Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

LPCN holding history

Lipocine Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LPCN overviewAll 13F holders of LPCNFull Q2 2026 holdings

Shares (Q2 2026)
3,596
Value
$9.21K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of LPCN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,596$9.21K<0.1%+102+2.9%AddedHolders
Q1 20263,494$27.9K<0.1%−2,109−37.6%ReducedHolders
Q4 20255,603$45.0K<0.1%+3,837+217.3%AddedHolders
Q3 20251,766$5.03K<0.1%+1,291+271.8%AddedHolders
Q2 2025475$1.50K<0.1%+276+138.7%AddedHolders
Q1 2025199$632<0.1%+196+6,533.3%AddedHolders
Q4 20243$15<0.1%−59,410−100.0%ReducedHolders
Q3 202459,413$266.8K<0.1%+3,192+5.7%AddedHolders
Q2 202456,221$463.3K<0.1%+55,790+12,944.3%AddedHolders
Q1 2024431$2.24K<0.1%+431NewHolders
Q4 20230$00.0%−42−100.0%Sold outHolders
Q3 202342$125<0.1%+42NewHolders
Q2 20230$00.0%−1,477−100.0%Sold outConverted for a 1-for-17 splitHolders
Q1 202325,113$7.99K<0.1%+13,650+119.1%AddedHolders
Q4 202211,463$4.58K<0.1%+10,963+2,192.6%AddedHolders
Q3 2022500$00.0%00.0%UnchangedHolders
Q2 2022500$00.0%−6,862−93.2%ReducedHolders
Q1 20227,362$10.0K<0.1%+3,362+84.1%AddedHolders
Q4 20214,000$4.00K<0.1%+1,926+92.9%AddedHolders
Q3 20212,074$2.00K<0.1%−4,711−69.4%ReducedHolders
Q2 20216,785$9.00K<0.1%+4,785+239.3%AddedHolders
Q1 20212,000$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.